ArticlePediatrics international : official journal of the Japan Pediatric Society
Comparison of Phenol Application and Endoscopic Pilonidal Sinus Treatment in Pediatric Pilonidal Sinus Disease.
Article in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe optimal treatment for pilonidal sinus disease remains controversial; however, minimally invasive methods are becoming increasingly common in children compared to traditional surgical approaches. This study aimed to compare the outcomes of two different minimally invasive methods for treating pediatric pilonidal sinus disease: phenol application and endoscopic pilonidal sinus treatment (EPSiT).
methodsChildren who underwent EPSiT or phenolization for pilonidal sinus disease between January 2016 and January 2023 were included in the study. The patients' age, sex, treatment method, number of phenol applications or EPSiT procedures, visual analog scale (VAS) pain scores at postoperative 3 h, length of hospital stay, time to return to daily activities, early postoperative complications, and recurrence were analyzed.
resultsA total of 61 patients were included in the study, 38 males (62.3%) and 23 females (37.7%). The mean age was 15.18 ± 1.7 years. Thirty patients (49.2%) were in the EPSiT treatment group, and 31 patients (50.8%) were in the phenol treatment group. Postoperative VAS pain scores were significantly higher in the phenolization group than in the EPSiT group (2.68 ± 1.92 vs. 1; p < 0.001). Time to return to daily activities, number of applications, early postoperative complications, and recurrence were significantly lower in the EPSiT group compared to the phenol group (p < 0.001, p < 0.001, p = 0.023, and p < 0.001, respectively).
conclusionFor pediatric pilonidal sinus disease, EPSiT was more advantageous than phenol treatment in terms of postoperative pain, time to return to daily routine, early complications, and recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.